Vitalsource Technologies, Inc. Glioblastoma | Kaicus USA

Vitalsource Technologies, Inc. Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America

110.99 USD

Brand: Elsevier HealthScience EN
Sponsored  This site contains affiliate links for which we may receive compensation. More information